Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.79
Delayed Data
As of 3:59pm ET
 +0.35 / +3.06%
Today’s Change
6.36
Today|||52-Week Range
16.81
+11.86%
Year-to-Date
Innoviva (INVA) Is Today's Strong On High Volume Stock
10:20am / TheStreet.com - Paid Partner Content
Sarepta (SRPT) Posts Y/Y Wider Q2 Loss, Eteplirsen in Focus
Jul 20 / Zacks.com - Paid Partner Content
What's in Store for VeriSign (VRSN) This Earnings Season?
Jul 26 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Label Expansion Under U.S., EU Review
Jul 19 / Zacks.com - Paid Partner Content
After GILD Earnings, Which Biomed Stock is Best Right Now?
Jul 26 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content
Changyou.com (CYOU) Q2 Earnings: Is a Surprise in Store?
Jul 26 / Zacks.com - Paid Partner Content
Merck KGaA's Multiple Sclerosis Drug under Review in EU
Jul 19 / Zacks.com - Paid Partner Content
Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Jul 26 / Zacks.com - Paid Partner Content
Evoke (EVOK) Stock Down on Poor Phase III EVK-001 Data
Jul 19 / Zacks.com - Paid Partner Content
Should You Buy Innoviva (INVA) Ahead of Earnings?
Jul 26 / Zacks.com - Paid Partner Content
Celgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma
Jul 18 / Zacks.com - Paid Partner Content
What's in Store for Waste Management (WM) in Q2 Earnings?
Jul 26 / Zacks.com - Paid Partner Content
athenahealth (ATHN) Q2 Earnings: What's in the Cards?
Jul 18 / Zacks.com - Paid Partner Content
Will Stericycle (SRCL) Disappoint this Earnings Season?
Jul 26 / Zacks.com - Paid Partner Content
ZIOPHARM (ZIOP) Stock Down on Patient Death in Phase I
Jul 18 / Zacks.com - Paid Partner Content
Will Ingersoll-Rand (IR) Surpass Q2 Earnings Estimates?
Jul 26 / Zacks.com - Paid Partner Content
Adeptus Health (ADPT) Q2 Earnings: Will it Beat Estimates?
Jul 18 / Zacks.com - Paid Partner Content
Will Synaptics (SYNA) Disappoint Again in Q4 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
St. Jude Medical (STJ) Q2 Earnings: What's in the Cards?
Jul 15 / Zacks.com - Paid Partner Content
Will Netgear's (NTGR) Earnings in Q2 Spring a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Raises Offer to Buy Monsanto to $125/Share
Jul 15 / Zacks.com - Paid Partner Content
Automatic Data (ADP) Q4 Earnings: Will it Surprise this Time?
Jul 25 / Zacks.com - Paid Partner Content
Gilead's HCV Drug Epclusa Gets Regulatory Nod in Canada
Jul 15 / Zacks.com - Paid Partner Content
Can Anthem (ANTM) Pull a Surprise this Earnings Season?
Jul 25 / Zacks.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase III rhGUS Data
Jul 15 / Zacks.com - Paid Partner Content
Actelion (ALIOF) Beats Q2 Earnings & Revenues, View Up
Jul 22 / Zacks.com - Paid Partner Content
Intuitive Surgical (ISRG) Q2 Earnings: What's in Store?
Jul 15 / Zacks.com - Paid Partner Content
Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus
Jul 22 / Zacks.com - Paid Partner Content
Geron (GERN) Gets Three Patents for Imetelstat in the U.S.
Jul 14 / Zacks.com - Paid Partner Content
Will Facebook (FB) Deliver Stellar Earnings Again in Q2?
Jul 22 / Zacks.com - Paid Partner Content
Eli Lilly, Boehringer Collaborate for Metastatic Breast Cancer
Jul 14 / Zacks.com - Paid Partner Content
Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook
Jul 21 / Zacks.com - Paid Partner Content
TrovaGene Inks Partnership with USC Norris Cancer Center
Jul 13 / Zacks.com - Paid Partner Content
Aegerion to Withdraw Juxtapid from EU, Reduces Workforce
Jul 21 / Zacks.com - Paid Partner Content
CytRx (CYTR) Stock Falls on Unfavorable Aldoxorubicin Data
Jul 13 / Zacks.com - Paid Partner Content
Zafgen Halts Development of Beloranib, to Cut Jobs by ~34%
Jul 20 / Zacks.com - Paid Partner Content